Trial intelligence / Profile preview

Usefulness of vitamin D on morbidity and mortality of SARS-CoV-2 virus infection (Covid-19) at the Central University Hospital of Asturias

2020-002274-28Phase 4Completed

Sponsor
FINBA
Start
May 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of cholecalciferol in coronavirus disease 2019 (COVID-19), sponsored by FINBA. Primary endpoints: Percentage of patients with negative SARS-CoV-2 viral load and Time to negative SARS-CoV-2 viral load. Started May 2020; status: completed.

02

Drugs

cholecalciferol
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on 2020-002274-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-002274-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call